Industry Clinic 鈥� Ad Insights Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC Dec 10, 2024
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns News, features, and commentary about cancer-related issues Dec 05, 2024
Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975 Prevention and screening efforts accounted for 80% of those averted deaths Dec 05, 2024
Durvalumab Wins FDA Approval in Limited-Stage SCLC Unprecedented 22.5-month improvement in median overall survival as consolidation therapy Dec 05, 2024
FDA OKs First Drug Targeting NRG1 Gene Fusion in Pancreatic, Lung Cancers Zenocutuzumab achieved response rates of 40% in pancreatic adenocarcinoma, 33% in advanced NSCLC Dec 04, 2024
Industry Clinic 鈥� Ad Insights What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean? Dec 04, 2024
Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests News, features, and commentary about cancer-related issues Nov 29, 2024
Early Promise for PI3K Inhibitor in Brain Metastases Also from SNO: TTFields boosts PFS in glioblastoma, proton therapy for leptomeningeal disease Nov 25, 2024
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis? News, features, and commentary about cancer-related issues Nov 22, 2024
Treatment of Oligometastatic EGFR-Mutant Lung Cancer More research needed on role of local therapy in new era of treatment Nov 22, 2024
Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer News, features, and commentary about cancer-related issues Nov 15, 2024
'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer News, features, and commentary about cancer-related issues Nov 08, 2024
Watch for Psoriasis After Cancer Immunotherapy, Study Says PD-1/PD-L1 inhibitors singled out for association Nov 07, 2024
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer News, features, and commentary about cancer-related issues Nov 01, 2024
Year in Review: Non-Small Cell Lung Cancer A look back at some of the newsworthy developments of 2024 Nov 01, 2024
Early Smoking Cessation After Cancer Diagnosis Tied to Better Survival Largest survival benefit observed in patients who entered a cessation program within 6 months Oct 31, 2024
Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted -- News, features, and commentary about cancer-related issues Oct 18, 2024
ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing? Debate highlights pros and cons of the new recommendation Oct 11, 2024
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer Osimertinib plus ramucirumab in first line shows 9-month PFS advantage over EGFR inhibition alone Oct 10, 2024
Checkpoint Inhibitors for Lung Cancer Linked to Pulmonary Embolism Study raises questions about how to assess patient risk, experts say Oct 08, 2024
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer News, features, and commentary about cancer-related issues Oct 04, 2024
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC Latest negative results emphasize "critical" aspect of immunotherapy timing Oct 02, 2024
FDA Expands Approval of Osimertinib in Lung Cancer EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy Sep 25, 2024
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic Actual rates for 2021 lagged behind projections Sep 25, 2024
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms? News, features, and commentary about cancer-related issues Sep 19, 2024
Novel Agent Effective for Cancer Wasting Disorder Cancer patients with cachexia added needed pounds with GDF-15 antibody Sep 18, 2024
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer News, features, and commentary about cancer-related issues Sep 12, 2024
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan Sep 11, 2024
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC However, plinabulin plus docetaxel still "not ready for prime time," expert says Sep 10, 2024
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC Absolute improvement of almost 30%, doubling of duration of response with savolitinib Sep 10, 2024
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC Two-trial analysis shows about a 40% decreased risk of disease recurrence or death Sep 09, 2024
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC Novel agent nearly halved risk of progression as first-line therapy in phase III trial Sep 09, 2024
Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer Add-on ADC, monoclonal antibody consistently increase pCR versus PD-1 inhibitor plus chemotherapy Sep 09, 2024
Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza' News, features, and commentary about cancer-related issues Aug 30, 2024
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC In Japanese trial, nivolumab-ipilimumab didn't improve OS versus pembrolizumab, had more toxicity Aug 22, 2024
Researchers Challenge USPSTF's Lung Cancer Screening Criteria Alternate criteria based on years of smoking has higher sensitivity and specificity, study says Aug 20, 2024
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer Lazertinib plus amivantamab improved PFS by about 7 months versus single-agent osimertinib Aug 20, 2024
Higher Steroid Dose for ICI Toxicity Harms Cancer Survival, Analysis Suggests More data for discussion of controversial association between steroids, immunotherapy Aug 19, 2024
FDA Expands Durvalumab Label to Operable Lung Cancer PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery Aug 16, 2024
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire News, features, and commentary about cancer-related issues Aug 09, 2024
